1. Bisphosphonates/methotrexate

   Case report 03 February 2018 Pages: 51 - 51

2. Bleomycin

   Case report 03 February 2018 Pages: 52 - 52

3. Bortezomib

   Case report 03 February 2018 Pages: 53 - 53

4. Bortezomib

   Case report 03 February 2018 Pages: 54 - 54

5. Brivaracetam

   Case report 03 February 2018 Pages: 55 - 55

6. Cabozantinib

   Case report 03 February 2018 Pages: 56 - 56

7. Capecitabine

   Case report 03 February 2018 Pages: 57 - 57

8. Capecitabine

   Case report 03 February 2018 Pages: 58 - 58

9. Capecitabine

   Case report 03 February 2018 Pages: 59 - 59

10. Carbamazepine

    Case report 03 February 2018 Pages: 60 - 60

11. Carbamazepine

    Case report 03 February 2018 Pages: 61 - 61

12. Cefepime

    Case report 03 February 2018 Pages: 62 - 62

13. Cefoperazone/tazobactam/doxycycline interaction

    Case report 03 February 2018 Pages: 63 - 63

14. Ceftriaxone

    Case report 03 February 2018 Pages: 64 - 64

15. Cemiplimab

    Case report 03 February 2018 Pages: 65 - 65

16. Certolizumab pegol

    Case report 03 February 2018 Pages: 66 - 66

17. Certolizumab pegol

    Case report 03 February 2018 Pages: 67 - 67

18. Cetuximab

    Case report 03 February 2018 Pages: 68 - 68

19. Chloral hydrate/clonidine/gabapentin

    Case report 03 February 2018 Pages: 69 - 69

20. Ciclosporin/prednisolone

    Case report 03 February 2018 Pages: 70 - 70

21. Ciprofloxacin

    Case report 03 February 2018 Pages: 71 - 71

22. Ciprofloxacin

    Case report 03 February 2018 Pages: 72 - 72

23. Cisplatin/docetaxel

    Case report 03 February 2018 Pages: 73 - 73

24. Citric acid/sodium citrate

    Case report 03 February 2018 Pages: 74 - 74

25. Clobetasol

    Case report 03 February 2018 Pages: 75 - 75

26. Clozapine

    Case report 03 February 2018 Pages: 76 - 76

27. Colistin

    Case report 03 February 2018 Pages: 77 - 77

28. Corifollitropin-α

    Case report 03 February 2018 Pages: 78 - 78

29. Corticosteroids/cholinesterase inhibitors/immune globulin/pembrolizumab

    Case report 03 February 2018 Pages: 79 - 79

30. Dabigatran-etexilate

    Case report 03 February 2018 Pages: 80 - 80

31. Dasatinib/nilotinib

    Case report 03 February 2018 Pages: 81 - 81

32. Denosumab/gemcitabine/sunitinib

    Case report 03 February 2018 Pages: 82 - 82

33. Dopamine

    Case report 03 February 2018 Pages: 83 - 83

34. Doxorubicin

    Case report 03 February 2018 Pages: 84 - 84

35. Doxorubicin-liposomal

    Case report 03 February 2018 Pages: 85 - 85

36. Doxycycline/meropenem/vancomycin

    Case report 03 February 2018 Pages: 86 - 86

37. Eculizumab

    Case report 03 February 2018 Pages: 87 - 87

38. Eculizumab/prednisolone

    Case report 03 February 2018 Pages: 88 - 88

39. Edoxaban

    Case report 03 February 2018 Pages: 89 - 89

40. Elvitegravir/emtricitabine/tenofovir-disoproxil-fumarate/cobicistat/triamcinolone interaction

    Case report 03 February 2018 Pages: 90 - 90

41. Enalapril

    Case report 03 February 2018 Pages: 91 - 91

42. Enoxaparin sodium/heparin

    Case report 03 February 2018 Pages: 92 - 92

43. Escitalopram/venlafaxine

    Case report 03 February 2018 Pages: 93 - 93

44. Etanercept

    Case report 03 February 2018 Pages: 94 - 94

45. Ethinylestradiol/norgestrel

    Case report 03 February 2018 Pages: 95 - 95

46. Fenofibrate

    Case report 03 February 2018 Pages: 96 - 96

47. Fingolimod

    Case report 03 February 2018 Pages: 97 - 97

48. Fingolimod

    Case report 03 February 2018 Pages: 98 - 98

49. Fingolimod/methylprednisolone

    Case report 03 February 2018 Pages: 99 - 99

50. Fluocinolone acetonide/triamcinolone

    Case report 03 February 2018 Pages: 100 - 100